openPR Logo
Press release

U.S. and EU-5 Prefilled Syringe Small Molecule Market Company Analysis and Forecast to 2024

03-24-2017 02:14 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

U.S. and EU-5 Prefilled Syringe Small Molecule Market Company

The top three players operating in the U.S. and EU-5 prefilled syringe small molecule market raked in a share of 70% in the overall market in 2015, observes Transparency Market Research. The players, Teva Pharmaceutical Industries Ltd., Mylan N.V., and Sanofi, have held a dominant position in the overall market for a significant period of time. Teva’s lion’s share is attributable to its popular drug brand known as Copaxone. These players have been thriving on intensive investment on research and development and product innovation. “Several pharmaceutical companies are focusing on developing large molecules development and significant product pipelines to gain a competitive edge,” states the lead author of this research report.

Obtain Report Details @ http://www.transparencymarketresearch.com/us-eu5-prefilled-syringe-small-molecule-market.html

According to the research report, the U.S. and EU-5 prefilled syringe small molecule market is expected to be worth US$17.1 bn by the end of 2024 as against US$9.15 bn in 2015. Analysts anticipate that the market will progress between the CAGR of 6.0 % to 8.0 % during the forecast period of 2016 and 2024.

Neurology Drugs to Remain in High Demand throughout Forecast Period

The neurology segment is the dominant segment in the overall market and is expected to lead the market with soaring sales of its popular drug brand Copaxone for treating multiple sclerosis (MS). By the end of 2024, the neurology drugs segment is expected to make a sale of 40.3 million units. In terms of regions, the U.S. is projected to acquire a share of 68.3% by the end of 2024.

Technological Innovations keep Momentum Steady in Overall Market

The U.S. and EU-5 prefilled syringe small molecule market is estimated to grow at a rapid pace in the coming few years due to incredible technological innovations. These innovations have brought in new materials and device functions for prefilled syringes. For instance, BD plans to launch COP (Cyclo-olefin-polymer) syringes that will be used for biopharmaceuticals. The biggest benefit of these syringes is that they have exceptionally low silicone, super low tungsten, and very low particles value. Manufacturers are also designing plastic syringes with COPs that have the advantage of ultra-high purity polymer with low off-gas and leachable content as compared to glass syringes.

Analysts predict that the demand for prefilled syringes will exhibit continued growth as they offer injectable drug delivery that can be easily performed at home. Thus, prefilled syringes have completely eliminated the need for hospitals and trained medical staff, thereby reducing the cost of healthcare for the patients. The ability to see the vials has also prompted the usage of prefilled syringes for managing diseases such as diabetes, rheumatoid arthritis, and kidney diseases.

For more information on this report, fill the form @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16988

Product Recalls Shadow Positive Perception and Hamper Market Growth

The shift in preference for large molecules biologics is estimated to restrain the demand for prefilled syringes for small molecules in the coming years. The market is also likely to be restrained by the growing concerns pertaining to the product quality and inaccuracy of dosage. These factors have also led to product recalls in the recent past. Against this background, several healthcare professionals are using other formulations of the same drug to treat the patients.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. and EU-5 Prefilled Syringe Small Molecule Market Company Analysis and Forecast to 2024 here

News-ID: 481453 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Transparency

Transparency Market Research
A belt drive is a type of power transmission device which is a looped belt wound around a pair of pulley so as to transmit power between two or more rotating shafts. Compared to other power transmitting devices, belt drives are more preferred in mechanical industry due to easy installation, numerous speed ratio selections, less power loss and comparative low price. Belt drive protects the rotating machinery from overload fluctuations
Transparency Market Research
An ultrasonic motor is an electric motor which is driven by the ultrasonic vibration of a component. The stator of the motor is supported by piezoelectric components in ultrasonic frequency range which produces different types of vibrations depending on its arrangement. In other words, ultrasonic motor is a type of electric motor that transforms ultrasonic physical vibrations to linear motion, produced by a piezo-transducer. Ultrasonic motors therefore do not use
Transparency Market Research
The global Li-Fi market is expected to exhibit growth at a robust pace between 2016 and 2023. Massive bandwidth owing to the growing RF spectrum crunch, together with a high degree of security and energy efficiency are expected to bolster the global Li-Fi market. While the features offered by Li-Fi and visible light communications (VLC) are quite similar, unlike the latter, Li-Fi does not require line-of-sight between receiver and transmitter. The
Transparency Market Research
A new research report published by Transparency Market Research states that the global dental bone graft substitutes and other biomaterials market is expected to grow due to the continuous rise in periodontal (gum) diseases along with growing incidence of dental fractures. The report, titled “Dental Bone Graft Substitutes and other Biomaterials Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020”, is available for sale on
eProcurement: Instant Transparency
ifm Achieves Better Prices in Indirect Procurement with JAGGAER solution Vienna | Research Triangle, NC, USA | Essen, August ​09​, 2017 – ifm, the specialist for sensors in automation technology, has said goodbye to manual processing in indirect procurement once and for all. With the eProcurement digital procurement tool from JAGGAER, provider of the world’s most comprehensive Source to Pay (S2P) indirect and direct solution suite, more than 6000 employees
More transparency in Engineering IT
CPO certification helps evaluate openness of IT systems Digitalization is making openness in the linking of IT solutions increasingly important. The Code of PLM Openness (CPO), developed by the ProSTEP iViP Association, supplies a concrete approach for achieving precisely that. Fraunhofer IAO has now developed an effective certification for companies, which helps them comply with the CPO criteria. Industrie 4.0 requires intensified collaboration between various tools and systems. Only when